San Diego Attorney Caleb Bates was quoted in “Framework established but uncertainty remains over ‘pay-for-delay’ drug payments,” an article published by Legal NewsLine.
Excerpt: An appeals court ruling in favor of two drug companies accused of hurting insurance plans, wholesalers and consumers by blocking the entry of a generic product to market will provide some framework for deciding future similar cases, according to an attorney. But the suit against Ranbaxy and AstraZeneca over a “reverse payment,” or a pay-for-delay, worth hundreds of millions of dollars, has to be evaluated in the shadow of a U.S. Supreme Court ruling that these disputes must be approached on a case-by-case basis.